Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Askari

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Therapeutic Advances in Hematology|October 9, 2025
Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in SpainCarlos Fernández de Larrea, Javier Loscertales, Valentín Cabañas, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 2, 2025
Development of PREVEMM: A Venous Thromboembolism Risk Score for Newly Diagnosed Multiple Myeloma PatientsInés Martínez-Alfonzo, Diego Velasco-Rodríguez, Pablo Mínguez-Paniagua, et al.
Plos One|March 4, 2021
Development and validation of a predictive model of in-hospital mortality in COVID-19 patientsDiego Velasco-Rodríguez, Juan-Manuel Alonso-Dominguez, Rosa Vidal Laso, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 23, 2020
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical studyHassan Abolghasemi, Peyman Eshghi, Abdol Majid Cheraghali, et al.
Journal of Thrombosis and Thrombolysis|January 11, 2023
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myelomaDiego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2025
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapyDiego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
Blood Advances|December 7, 2020
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trialMeletios Dimopoulos, Ramon Garcia Sanz, Hui-Peng Lee, et al.
Iranian Journal of Pharmaceutical Research : IJPR|June 29, 2022
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, et al.
Blood Advances|August 19, 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysisAndrew Spencer, Maria Gavriatopoulou, Daniel Coriu, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Therapeutic Advances in Hematology|October 9, 2025
Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in SpainCarlos Fernández de Larrea, Javier Loscertales, Valentín Cabañas, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 2, 2025
Development of PREVEMM: A Venous Thromboembolism Risk Score for Newly Diagnosed Multiple Myeloma PatientsInés Martínez-Alfonzo, Diego Velasco-Rodríguez, Pablo Mínguez-Paniagua, et al.
Plos One|March 4, 2021
Development and validation of a predictive model of in-hospital mortality in COVID-19 patientsDiego Velasco-Rodríguez, Juan-Manuel Alonso-Dominguez, Rosa Vidal Laso, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 23, 2020
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical studyHassan Abolghasemi, Peyman Eshghi, Abdol Majid Cheraghali, et al.
Journal of Thrombosis and Thrombolysis|January 11, 2023
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myelomaDiego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2025
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapyDiego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, et al.
Blood Advances|December 7, 2020
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trialMeletios Dimopoulos, Ramon Garcia Sanz, Hui-Peng Lee, et al.
Iranian Journal of Pharmaceutical Research : IJPR|June 29, 2022
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, et al.
Blood Advances|August 19, 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysisAndrew Spencer, Maria Gavriatopoulou, Daniel Coriu, et al.
Pageof 6